Divesa Pharma registered with NMRA
Pharma company, Divesa Pharma Limited, has stated that the National Medicines Regulatory Authority (NMRA) has issued them a licence on 18 August 2018 to sell medicine by wholesale.
The company has issued a statement in this regard, refuting the allegations levelled by Minister of Health Dr. Nalinda Jayatissa at the Parliament recently.
The statement notes that the license was “continuously renewed to date.”
“As such, Divasa Pharma has legitimately marketed and sold Covid-19 PCR and RAT kits to the local market including to public healthcare institutions and private healthcare institutions, under guidelines issued by the Ministry of Health. These PCR and RAT Kits were sold at the NMRA stipulated price or less,” the company said in a statement.
The pharma company further highlighted that it participated in a transparent tender procurement process, and fulfilled “all necessary requirements” as a local authorized distributor of such products.
